Apyx Medical Corp expected to post a loss of 16 cents a share - Earnings Preview

Apyx Medical

11/03/2025 12:36

Apyx Medical Corp APYX.OQ APYX.O is expected to show a fall in quarterly revenue when it reports  results on March 13 for the period ending December 31 2024

The Clearwater Florida-based  company is expected to report a 8.7% decrease in revenue to $13.388 million from $14.66 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on January 13 2025, for the period ended December 31, was for revenue between $14.10 million and $14.30 million.

‚ÄčLSEG's mean analyst estimate for Apyx Medical Corp is for a loss of 16 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Apyx Medical Corp is $3.00‚Äč, above‚Äč its last closing price of $1.12. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.19
-0.19
-0.14
Beat
24.6
Jun. 30 2024
-0.20
-0.20
-0.19
Beat
4.1
Mar. 31 2024
-0.22
-0.21
-0.22
Missed
-2.6‚Äč
Dec. 31 2023
-0.20
-0.18
-0.28
Missed
-57.7
‚Äč‚ÄčSep. 30 2023
-0.12
-0.11
-0.13
Missed
-14.8
Jun. 30 2023
-0.07
-0.07
-0.11
Missed
-58.5‚Äč
Mar. 31 2023
-0.16
-0.13
-0.10
Beat
25.9
Dec. 31 2022
-0.15
-0.14
-0.17
Missed
-19.3

This summary was machine generated March 11 at 12:36 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)